PF-4856883

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePF-4856883
Drug Alias NameCVX-096CovX 096PF-4856883PF-04856883
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsEndocrine System DiseasesDiabetes Mellitus, Type 2Diabetes Mellitus +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System DiseasesDiabetes Mellitus, Type 2Diabetes Mellitus +[5] 

Other Information

ATC CodeN/A
Related LinksN/A